STEVEN HUDOCK: Open Payments
NPI 1033109749 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 59 payments from 25 companies in 2025. Trend: 2023 $1,336 · 2024 $1,422 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $301 |
| GlaxoSmithKline, LLC. | 4 | $167 |
| ABBVIE INC. | 3 | $148 |
| Terumo Medical Corporation | 1 | $143 |
| PFIZER INC. | 5 | $108 |
| Amgen Inc. | 5 | $87 |
| Abbott Laboratories | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $39 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
Products named: Ozempic, NAVICROSS, UBRELVY, AREXVY, PREVNAR 20, EVENITY, Wegovy, FREESTYLE LIBRE 3.
Industry payments across MI — which companies pay providers there.
